SO-4 phase Ib/II, open-label, randomised evaluation of atezolizumab plus RO6874281 vs control in MORPHEUS–pancreatic ductal adenocarcinoma
2020
-
Correction
-
Source
-
Cite
-
Save
0
References
1
Citations
NaN
KQI